Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    F-18 RGD-K5
Show Display Options
Rank Status Study
1 Completed Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
Conditions: Sarcoma;   Melanoma;   Lung Cancer;   Breast Cancer;   High Grade Gliomas
Intervention: Drug: F-18 RGD-K5
2 Completed Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
Conditions: Metastatic Breast Cancer;   Metastatic Colon/Rectum Cancer;   Non-squamous Non-small Cell Lung Cancer
Intervention: Drug: [F-18]RGD-K5
3 Terminated
Has Results
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
Condition: Carotid Stenosis
Intervention: Drug: [F-18]RDG-K5
4 Terminated TRACER RGD-K5 Carotid Plaque Imaging Study
Conditions: Carotid Artery Disease;   Carotid Stenosis
Intervention: Drug: [F-18] RDG-K5
5 Unknown  RGD-K5 in Head and Neck Cancer Patients
Condition: Head and Neck Neoplasms

Study has passed its completion date and status has not been verified in more than two years.